These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31776599)

  • 1. Developing vaccines against epidemic-prone emerging infectious diseases.
    Bernasconi V; Kristiansen PA; Whelan M; Román RG; Bettis A; Yimer SA; Gurry C; Andersen SR; Yeskey D; Mandi H; Kumar A; Holst J; Clark C; Cramer JP; Røttingen JA; Hatchett R; Saville M; Norheim G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):65-73. PubMed ID: 31776599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEPI: Driving Progress Toward Epidemic Preparedness and Response.
    Gouglas D; Christodoulou M; Plotkin SA; Hatchett R
    Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding equipoise: CEPI revises its equitable access policy.
    Huneycutt B; Lurie N; Rotenberg S; Wilder R; Hatchett R
    Vaccine; 2020 Feb; 38(9):2144-2148. PubMed ID: 32005536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
    Fathi A; Dahlke C; Addo MM
    Hum Vaccin Immunother; 2019; 15(10):2269-2285. PubMed ID: 31368826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak response as an essential component of vaccine development.
    Hatchett R; Lurie N
    Lancet Infect Dis; 2019 Nov; 19(11):e399-e403. PubMed ID: 31256955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for epidemic infections and the role of CEPI.
    Plotkin SA
    Hum Vaccin Immunother; 2017 Dec; 13(12):2755-2762. PubMed ID: 28375764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.
    Zumla A; Dar O; Kock R; Muturi M; Ntoumi F; Kaleebu P; Eusebio M; Mfinanga S; Bates M; Mwaba P; Ansumana R; Khan M; Alagaili AN; Cotten M; Azhar EI; Maeurer M; Ippolito G; Petersen E
    Int J Infect Dis; 2016 Jun; 47():5-9. PubMed ID: 27321961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context.
    Kojom LP; Singh V
    Vector Borne Zoonotic Dis; 2021 Mar; 21(3):149-159. PubMed ID: 33316200
    [No Abstract]   [Full Text] [Related]  

  • 10. New technologies for controlling emerging infectious diseases in Guinea and the Democratic Republic of the Congo: their role in response to the Ebola epidemic.
    Ayouba A; Mbala-Kingebeni P; Keita AK; Vidal N; Lacroix A; Touré A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S
    Med Sante Trop; 2019 Nov; 29(4):362-365. PubMed ID: 31884982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of major disease outbreaks in the African region, 2003-2007.
    Kebede S; Duales S; Yokouide A; Alemu W
    East Afr J Public Health; 2010 Mar; 7(1):20-9. PubMed ID: 21413568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergent threats: lessons learnt from Ebola.
    Piot P; Soka MJ; Spencer J
    Int Health; 2019 Sep; 11(5):334-337. PubMed ID: 31385587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program.
    Gupta SB; Coller BA; Feinberg M
    Expert Rev Vaccines; 2018 Oct; 17(10):913-923. PubMed ID: 30269612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting vaccine demand and impact for emerging zoonotic pathogens.
    Lerch A; Ten Bosch QA; L'Azou Jackson M; Bettis AA; Bernuzzi M; Murphy GAV; Tran QM; Huber JH; Siraj AS; Bron GM; Elliott M; Hartlage CS; Koh S; Strimbu K; Walters M; Perkins TA; Moore SM
    BMC Med; 2022 Jun; 20(1):202. PubMed ID: 35705986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
    Voss G; Jacquet JM; Tornieporth N; Kampmann B; Karron R; Meulen AS; Chen R; Gruber M; Lurie N; Weller C; Cramer JP; Saville M; Darko M
    Vaccine; 2021 Dec; 39(51):7357-7362. PubMed ID: 34799142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines, inspiring innovation in health.
    Pagliusi S; Dennehy M; Kim H;
    Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation.
    Nichol AA; Antierens A
    PLoS One; 2021; 16(2):e0246320. PubMed ID: 33529237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
    Noad RJ; Simpson K; Fooks AR; Hewson R; Gilbert SC; Stevens MP; Hosie MJ; Prior J; Kinsey AM; Entrican G; Simpson A; Whitty CJM; Carroll MW
    Vaccine; 2019 Oct; 37(43):6241-6247. PubMed ID: 31522809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
    Gilbert SC; Warimwe GM
    Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.
    Jonkmans N; D'Acremont V; Flahault A
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34531189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.